Diabetes and Endocrine Wellness Center -- News

Dear Valued Patient,

We have been staying up to date on all news and information regarding the COVID-19 virus (Coronavirus). Your safety and the safety of our team is of paramount importance to us. We want to share with you our response to the current pandemic.

In response to COVID19, we are limiting our in office visits. Your visit may be changed to a video visit. If you are changed to a video visit, you will keep your current appointment date and time. You will receive a text on the day of your appointment with instructions.

We are taking this situation very seriously and are taking every precaution. We encourage you to do the same. We are asking that all individuals wear a mask while in our office. We are also limiting the number of people in our office at any one time and ask that you do not bring any guests with you to your visit. We apologize for any inconvenience this may cause. Please remember that continuing to take care of yourself is especially important during this time. If you have any questions, please contact us via your patient portal. Alternatively, you may call us at 256-881-2700.

Best Regards,

Diabetes and Endocrine Wellness Center

On May 15, 2019, the State Committee of Public Health voted to make gabapentin a scheduled V medication, effective November 18, 2019. This decision was based on its potential for abuse and the need to properly monitor how it is prescribed in Alabama.
 

Effective November 1, 2019, our practice will no longer prescribe gabapentin for patients. Neuropathy is a common complication of diabetes and we will be happy to refer you to a neurologist to treat your neuropathic symptoms.  

Beginning: January 2019

For all our patients with diabetes, our office will no longer complete government forms/letters for diabetic patients who operate a commercial vehicle.